Hepatocyte Growth Factor (HGF) Stimulates Tumor Cells to Release Chemokines Active in Recruiting Dendritic Cells

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of chemokines in the regulation of dendritic cell trafficking

  1999cited by this paper
• Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma.

  1999cited by this paper
• Hepatocyte growth factor (HGF) stimulates tumour invasiveness in papillary carcinoma of the thyroid

  1999cited by this paper
• The chemokine system: redundancy for robust outputs.

  1999cited by this paper
• Expression of Met protein and urokinase‐type plasminogen activator receptor (uPA‐R) in papillary carcinoma of the thyroid

  1998cited by this paper
• Coexistent thyroiditis is associated with lower tumour stage in thyroid carcinoma

  1998cited by this paper
• Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties.

  1998cited by this paper
• Expression of the Hepatocyte Growth Factor and c-met in Normal Thyroid, Non-neoplastic, and Neoplastic Nodules

  1998cited by this paper
• Selective Recruitment of Immature and Mature Dendritic Cells by Distinct Chemokines Expressed in Different Anatomic Sites

  1998cited by this paper
• Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses.

  1998cited by this paper
• Chronic Thyroiditis as a Favorable Prognostic Factor in Papillary Thyroid Carcinoma

  1998cited by this paper
• Langerhans cell histiocytosis associated with papillary carcinoma of the thyroid

  1998cited by this paper
• Origin, maturation and antigen presenting function of dendritic cells.

  1997cited by this paper
• Langerhans cell histiocytosis of lymph nodes: draining a papillary carcinoma of the thyroid

  1997cited by this paper
• Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas.

  1996cited by this paper
• EXPRESSION OF Met PROTEIN IN THYROID TUMOURS

  1996cited by this paper
• Expression of monocyte chemoattractant protein‐1 mRNA and protein in cultured human thyrocytes

  1996cited by this paper
• Langerhans cell histiocytosis of the thyroid: a series of seven cases and a review of the literature.

  1996cited by this paper
• Biological Activation of pro-HGF (Hepatocyte Growth Factor) by Urokinase Is Controlled by a Stoichiometric Reaction (*)

  1995cited by this paper
• Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines.

  1995cited by this paper
• Eosinophilic granuloma of lymph nodes associated with metastatic papillary carcinoma of the thyroid

  1992cited by this paper
• Thyroid follicular cells produce interleukin-8.

  1992cited by this paper
• The origin and function of tumor-associated macrophages.

  1992cited by this paper
• C-terminal truncated forms of Met, the hepatocyte growth factor receptor

  1991cited by this paper
• Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data.

  1988cited by this paper
• Scatter factor is a fibroblast-derived modulator of epithelial cell mobility

  1987cited by this paper
• Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy

  1985cited by this paper
• Autoregulation by iodine of thyroid protein synthesis: influence of iodine on amino acid transport in cultured thyroid cells.

  1984cited by this paper

• The role of lactate metabolism-related LncRNAs in the prognosis, mutation, and tumor microenvironment of papillary thyroid cancer

  2023cites this paper
• The DARC Side of Inflamm-Aging: Duffy Antigen Receptor for Chemokines (DARC/ACKR1) as a Potential Biomarker of Aging, Immunosenescence, and Breast Oncogenesis among High-Risk Subpopulations

  2022cites this paper
• Cell Component and Function of Tumor Microenvironment in Thyroid Cancer

  2022cites this paper
• The Immune Landscape of Papillary Thyroid Cancer in the Context of Autoimmune Thyroiditis

  2022cites this paper
• Intraoperative MET-receptor targeted fluorescent imaging and spectroscopy for lymph node detection in papillary thyroid cancer: novel diagnostic tools for more selective central lymph node compartment dissection

  2022cites this paper
• CCL20 induces colorectal cancer neoplastic epithelial cell proliferation, migration, and further CCL20 production through autocrine HGF-c-Met and MSP-MSPR signaling pathways

  2021cites this paper
• Combination strategies to maximize the benefits of cancer immunotherapy

  2021cites this paper
• Role of Chemokines and Chemokine Receptors in Cancer

  2020cites this paper
• Progression and dormancy in metastatic thyroid cancer: concepts and clinical implications

  2020cites this paper
• Immune Microenvironment of Thyroid Cancer

  2020influential citation
• Functional Role of Dendritic Cell Subsets in Cancer Progression and Clinical Implications

  2020cites this paper
• Immune and Inflammatory Cells in Thyroid Cancer Microenvironment

  2019influential citation
• The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition

  2019cites this paper
• Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy

  2019influential citation
• Targeting HGF with Antibodies as an Anti‐Cancer Therapeutic Strategy

  2018cites this paper
• Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player?

  2018cites this paper
• Patterns of FOXE 1 Expression in Papillary Thyroid Carcinoma

  2018cites this paper
• Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a “Hammer” and “Anvil”

  2017cites this paper
• Leveraging the immune system to treat advanced thyroid cancers.

  2017cites this paper
• Étude de l’effet de l’injection de Cellules Stromales Mésenchymateuses sur un modèle de fibrose colorectale radio-induite chez le rat

  2016cites this paper
• Chemokines accentuating protumoral activities in oral cancer microenvironment possess an imperious stratagem for therapeutic resolutions.

  2016cites this paper
• DOWN-REGULATION OF ATYPICAL CHEMOKINE RECEPTOR ACKR2/D6 EXPRESSION BY HEMATOPOIETIC PROGENITORS PROMOTES MYELOID CELL MOBILIZATION AND DIFFERENTIATION

  2016influential citation
• The immune network in thyroid cancer

  2016cites this paper
• A multi-targeted approach to suppress tumor-promoting inflammation.

  2015cites this paper
• Chemokines as effector and target molecules in vascular biology.

  2015cites this paper
• Role of Chemokines and Chemokine Receptors in Cancer

  2015cites this paper
• Hepatocyte growth factor: A regulator of inflammation and autoimmunity.

  2015cites this paper
• Migration Stimulating Factor : new marker for tumour progression?

  2015cites this paper
• Inflammatory and Innate Immune Cells in Cancer Microenvironment and Progression

  2015cites this paper
• Duodenal follicular lymphoma: Comprehensive gene expression analysis with insights into pathogenesis

  2014cites this paper
• Tumor-Associated Inflammatory Cells in Thyroid Carcinomas.

  2014cites this paper
• Chapter 27 – Tumor-associated Macrophages in Cancer Growth and Progression

  2013cites this paper
• and Langerhans Cell Development While IL-4 IL-10 Induces CCR6 Expression During

  2013cites this paper
• T Cell and Antigen-Presenting Cell Subsets in the Tumor Microenvironment

  2013cites this paper
• TGF-beta/Smad pathway and BRAF mutation play different roles in circumscribed and infiltrative papillary thyroid carcinoma

  2012cites this paper
• Intracellular Signal Transduction and Modification of the Tumor Microenvironment Induced by RET/PTCs in Papillary Thyroid Carcinoma

  2012cites this paper
• The pros and cons of chemokines in tumor immunology.

  2012cites this paper
• Inflammation in thyroid oncogenesis.

  2012cites this paper
• Review Article Inflammation in thyroid oncogenesis

  2012cites this paper
• A study on crosstalk between lung carcinoma and immune cells

  2012cites this paper
• Role of Oncogene-Induced Senescence in Thyroid Carcinogenesis

  2012cites this paper
• A case of adult-onset Still’s disease (AOSD)-like manifestations abruptly developing during confirmation of a diagnosis of metastatic papillary thyroid carcinoma

  2012cites this paper
• Chemokines in health and disease.

  2011cites this paper
• The role of tumor-infiltrating MDSC subsets in tumor progression

  2011cites this paper
• Hypoxia-Inducible Factor in Thyroid Carcinoma

  2011cites this paper
• Diacylglycerol kinases are essential for hepatocyte growth factor‐dependent proliferation and motility of Kaposi’s sarcoma cells

  2011cites this paper
• Bystander cytotoxicity in human medullary thyroid carcinoma cells mediated by fusion yeast cytosine deaminase and 5-fluorocytosine.

  2011cites this paper
• Effect of the Hepatocyte Growth Factor on Allergic Inflammatory Cells

  2010cites this paper
• Mast cells have a protumorigenic role in human thyroid cancer

  2010cites this paper
• Modulation des cellules dendritiques et macrophages : implications dans le cancer et l'athérosclérose

  2010cites this paper
• Tumor‐associated macrophages (TAM) as major players of the cancer‐related inflammation

  2009cites this paper
• International Doctorate Program in Molecular Oncology and Endocrinology Doctorate School in Molecular Medicine

  2009cites this paper
• The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies

  2009cites this paper
• Activation of tumor-infiltrating antigen presenting cells by high intensity focused ultrasound ablation of human breast cancer.

  2009cites this paper
• Immunocytochemical investigation of Langerin (CD207) is a valuable adjunct in the cytological diagnosis of Langerhans cell histiocytosis of the thyroid.

  2009cites this paper
• Site-specific anti-tumor immunity : differences in DC function , TGF-production and numbers of intratumoral Foxp 3 + regulatory T cells

  2009cites this paper
• Dendritic Cell Expression of CD83 in Solitary Thyroid Nodules

  2009cites this paper
• Site‐specific anti‐tumor immunity: Differences in DC function, TGF‐β production and numbers of intratumoral Foxp3+ Treg

  2009cites this paper
• Cellular and molecular pathways linking inflammation and cancer.

  2009cites this paper
• Trafficking of Dendritic Cells in the Tumor Environment

  2009cites this paper
• COX‐2 is induced by HGF stimulation in Met‐positive thyroid papillary carcinoma cells and is involved in tumour invasiveness

  2009cites this paper
• Dendritic cells in cancer

  2009cites this paper
• Inflammation and Angiogenesis: Innate Immune Cells as Modulators of Tumor Vascularization

  2008cites this paper
• Mycoplasma and tumors: synergistic effect on humanmonocyte-derived dendritic cells immunosuppressing activity

  2008cites this paper
• Linking inflammation reactions to cancer: novel targets for therapeutic strategies.

  2008cites this paper
• Increased pressure stimulates aberrant dendritic cell maturation

  2008cites this paper
• Macrophage polarization in tumour progression.

  2008cites this paper
• Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases

  2008cites this paper
• International Doctorate Program in Molecular Oncology and Endocrinology Doctorate School in Molecular Medicine

  2007cites this paper
• Role of chemokines in tumor growth.

  2007cites this paper
• Hepatocyte Growth Factor Significantly Suppresses Collagen-Induced Arthritis in Mice

  2007cites this paper
• Targeting tumour-associated macrophages

  2007cites this paper
• Tumor promotion by tumor-associated macrophages.

  2007cites this paper
• International Doctorate Program in Molecular Oncology and Endocrinology Doctorate School in Molecular Medicine

  2007cites this paper
• Mice Suppresses Collagen-Induced Arthritis in Hepatocyte Growth Factor Significantly

  2007cites this paper
• Tumor-Associated Macrophages in Cancer Growth and Progression

  2007cites this paper
• Chemokine and Receptor Expression in Tumor Progression

  2007cites this paper
• Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy.

  2006cites this paper
• Ductal Metaplasia in Chronic Lymphocytic Thyroiditis as a Manifestation of Phylogenic Regression to an Exocrine Structure

  2006cites this paper
• Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene.

  2005cites this paper
• A Novel Role of Hepatocyte Growth Factor as an Immune Regulator through Suppressing Dendritic Cell Function1

  2005cites this paper
• Characterization of CCL20 secretion by human epithelial vaginal cells: involvement in Langerhans cell precursor attraction

  2005cites this paper
• Well differentiated thyroid carcinoma is associated with human lymphocyte antigen D‐related 11 in Eastern Hungarians

  2005cites this paper
• Characterization of dendritic cells in differentiated thyroid cancer

  2005influential citation
• The Role of Chemokines and their Receptors in Tumor Progression and Invasion: Potential New Targets of Biological Therapy

  2005cites this paper
• Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels.

  2004cites this paper
• Role of infiltrated leucocytes in tumour growth and spread

  2004cites this paper
• Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression.

  2004cites this paper
• ACTIVATION OF THE HGF / MET SYSTEM IN PAPILLARY THYROID CANCER: BIOLOGICAL EFFECTS OF HGF IN THYROID CANCER CELLS DEPEND ON MET EXPRESSION LEVELS

  2004cites this paper
• Regulation of the trafficking of tumour-infiltrating dendritic cells by chemokines.

  2004cites this paper
• Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors.

  2004cites this paper
• The fibroblast: Sentinel cell and local immune modulator in tumor tissue

  2004cites this paper
• Proinflammatory Mediators and Genetic Background in Oncogene Mediated Tumor Progression1

  2004cites this paper
• Increased expression of Met protein is associated with up‐regulation of hypoxia inducible factor‐1 (HIF‐1) in tumour cells in papillary carcinoma of the thyroid

  2004cites this paper
• [Immunohistochemical analysis of CD83, CD8 and CD4 positive cells in renal cell carcinoma].

  2004cites this paper
• Molecular signaling in thyroid cancer.

  2004cites this paper
• The CC chemokine CCL20 and its receptor CCR6.

  2003cites this paper
• Role of CD4+ T lymphocytes in antitumor immunity.

  2003cites this paper
• Expression of the c-Met proto-oncogene and its possible involvement in liver invasion in adult T-cell leukemia.

  2003cites this paper
• Tumor-Associated Macrophages and Dendritic Cells as Prototypic Type II Polarized Myeloid Populations

  2003cites this paper